Abstract
The philosophical principle behind benefit sharing is simple. Those who contribute to scientific research ought to share in its benefits. This is a matter of justice. If benefit sharing does not take place, exploitation may have occurred. The term “benefit sharing” was popularized by the Convention on Biological Diversity (CBD), which was adopted at the Earth Summit in Rio in 1992. This chapter provides an overview of the key international instruments and guidelines that make provisions for benefit sharing. Legal instruments are often categorized as to whether they are binding or non-binding. With the exception of the CBD itself most benefit sharing provisions are non-binding. All other key instruments presented here – the Declaration of Helsinki, the CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects, the HUGO Ethics Committee’s Statement on Benefit Sharing, and UNESCO’s Universal Declaration on the Human Genome and Human Rights, and Universal Declaration on Bioethics and Human Rights – are non-binding. Yet even when the law is clear and binding, compliance is not usually easily achieved. The access and benefit-sharing provisions of the CBD have been incorporated into national law in many countries world-wide, but success stories are still hard to find. It is hoped that the 2010 Nagoya Protocol to the CBD will address this shortfall for non-human biological resources. An example from Brazilian national legislation, which is discussed here, is encouraging in terms of achieving benefit sharing with those providing access to human biological resources. However at the global level, benefit sharing for human biological resources remains an unresolved and often contentious issue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
This revision and the Clinton administration’s role in imposing it are discussed in Pogge (2008: 131–132).
- 2.
- 3.
‘The Conference of the Parties … [r]eaffirms that human genetic resources are not included within the framework of the Convention’ (CBD COP Decision II/11, paragraph 2, http://www.cbd.int/decision/cop/?id=7084).
- 4.
United States (IP/C/W/434). See also proposals from Australia, (IP/C/W/310) and Japan (IP/C/W/236). (Sources referred to in these notes with numbers commencing ‘IP/C’ are working documents of the Council for TRIPS.)
- 5.
African Group (IP/C/W/404); Kenya (IP/C/M/47); Brazil, India, Pakistan, Peru, Thailand and Venezuela (IP/C/W/429/Rev.1); India(IP/C/W/198).
- 6.
Australia(IP/C/M/48); Canada(IP/C/M/47); New Zealand (IP/C/M/47); Andean community (IP/C/M/37/Add.1, paragraph 231); Brazil(IP/C/W/228); China(IP/C/M/47, paragraph 57).
- 7.
For the text of the decision adopting the protocol, see http://www.cbd.int/decision/cop/?id=12267.
- 8.
Since the protocol’s adoption, a group of indigenous organizations has sent a submission to the executive secretary of the CBD secretariat outlining ‘substantive and procedural injustices’ (http://www.ubcic.bc.ca/files/PDF/NagoyaProtocol_IGCJointSubmission_060111.pdf) – for instance, the fact that ‘excessive reliance on national legislation is likely to lead to serious abuses, in light of the history of violations’ and the lack of ‘full and effective participation’ by indigenous representatives during the negotiations.
- 9.
This development, the mentioning of human pathogens in the Nagoya Protocol, marks a departure from the approach otherwise taken in CBD legislation, which since 1995 excludes material of human origin.
- 10.
It should be noted that prior to the Second World War, no international ethical standards existed to regulate research on human subjects. National standards were also scarce. For a detailed look at the history and development of the Declaration of Helsinki see Human and Fluss (2001).
- 11.
See Andanda (2006: 60–61) for a detailed discussion of this regime.
- 12.
- 13.
We agree with Udo Schuklenk on this claim. When comparing the Declaration of Helsinki with other influential guidelines, Schuklenk argues that ‘an international consensus among smallish operators with impressive names is not a sufficient reason to do away with the authority of the WMA, which represents more members of the medical profession in one single country, let alone across the world, than the rest of the organisations and institutions mentioned … combined’. See Schuklenk (2004: 196).
- 14.
Interview with a member of the Kenya Medical Research Institute (KEMRI) Ethical Review Committee quoted in Andanda and Cook Lucas (2007).
- 15.
For a detailed discussion of these two concepts of justice in the context of benefit sharing, see Schroeder and Pogge (2009: 274).
- 16.
- 17.
For a detailed analysis of the concept of solidarity in the context of benefit sharing see Simm (2006).
- 18.
Thanks to Bruno Schlemper Junior for providing an up-date on Brazilian national legislation to DS.
References
Albert B (2005) Biomedical research, ethnic labels, and anthropological responsibility: further comments. In: Borofsky R (ed) Yanomami: the fierce controversy and what we can learn from it. University of California Press, Berkeley and Los Angeles, pp 157–168
Andanda P (2006) The law and regulation of clinical research: interplay with public policy and bioethics. Focus Publishers Ltd., Nairobi
Andanda P (2008) Human-tissue related inventions: ownership and intellectual property rights in international collaborative research in developing countries. J Med Ethics 34(3):171–179
Andanda P, Lucas JC (2007) Majengo HIV/AIDS research case. A report for GenBenefit. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_nairobi_case.pdf
Brownlie I (2003) Principles of public international law. Oxford University Press, New York
CBD (1992) Convention on Biological Diversity. http://www.cbd.int/convention/text
CBD (2010) Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity. http://www.cbd.int/abs/doc/protocol/nagoya-protocol-en.pdf
Chadwick R, Berg K (2001) Solidarity and equity: new ethical frameworks for genetic databases. Sci Soc 2:318–321
CIOMS (2002) International ethical guidelines for biomedical research involving human subjects. Council for International Organizations of Medical Sciences. http://www.cioms.ch/publications/layout_guide2002.pdf
Dutfield G (2011) Summing up the Nagoya Protocol: fairness and bio-knowledge: the Nagoya Protocol. Workshop at the School of Law, University of Warwick, 17 June
Egziabher TBG (1994) The Convention on Biological Diversity, intellectual property rights and the interests of the South. In: Shiva V (ed) Biodiversity conservation: Whose resources? Whose knowledge? Indian National Trust for Art and Cultural Heritage, New Delhi, pp 198–215
Emanuel EJ, Wendler D, Killen J, Grady C (2004) What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis 189:930–937
European Commission (2010) Can we stop biodiversity loss by 2020? 19 January. http://ec.europa.eu/news/environment/100119_en.htm
Faunce TA (2005) Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration. J Med Ethics 31:173–178
Fidler DP (2001) ‘Geographical morality’ revisited: international relations, international law and the controversy over placebo controlled HIV clinical trials in developing countries. Harvard Int Law J 42:288–354
Haira A (2006) Prior and informed consent: an introduction. Presentation, New Zealand Ministry of Economic Development. http://www.med.govt.nz/upload/34619/haira.pdf
HUGO Ethics Committee (2000a) Statement on benefit-sharing, 9 April. http://www.hugo-international.org/img/benefit_sharing_2000.pdf
HUGO Ethics Committee (2000b) Editorial: Genetic benefit sharing. Science 290(5489):49
Human D, Fluss SS (2001) The World Medical Association’s Declaration of Helsinki: historical and contemporary perspectives. World Medical Association. http://www.wma.net/en/20activities/10ethics/10helsinki/draft_historical_contemporary_perspectives.pdf
ICJ (n.d.) Statute of the international Court of Justice. http://www.icj-cij.org/documents/index.php?p1=4&p2=2&p3=0&PHPSESSID=8755b5295491e0553df37fa930e1edcc
IISD and Stratos Inc. (2007) Volume 1: The ABS best practice standard. ABS-management tool best practice standard and handbook for implementing genetic resource access and benefit-sharing activities. State Secretariat for Economic Affairs, Swiss Confederation, Bern. http://www.iisd.org/pdf/2007/abs_mt.pdf
King KM (1998) A proposal for effective international regulation of biomedical research involving human subjects. Stanf J Int Law 34:163–206
Kleba J (2011) Access and benefit sharing in the light of justice as fairness. 17 June. Fairness and bio-knowledge: the Nagoya Protocol. Workshop at the School of Law, University of Warwick
Knoppers BM, Chadwick R, Takebe H, Berg K, Cantu JM, Daar AS, Engels EM, Kirby M, Macer D, Murray TH, Qiu R-Z, Verma IC, Wertz DC (2000) HUGO urges genetic benefit sharing. Community Genet 3(2):88–92
Macpherson CC (2007) Global bioethics: did the universal declaration on bioethics and human rights miss the boat? J Med Ethics 33:588–590
Merali Z, Singer PA, Boulyjenkov V, Daar AS (2004) The ELSI genetics regulatory resource kit: a tool for policymakers in developing countries. J Law Med Ethics 32(4):692–700
Mooney PR (1969) Seeds of the earth: a private or public resource? International Coalition for Development Action, London
National Health Council (Brazil) (1996) Resolution No. 196/96 on research involving human subjects. http://ww2.prefeitura.sp.gov.br//arquivos/secretarias/saude/organizacao/cepsms/0009/Reso196_English.pdf
National Health Council (Brazil) (1997) Resolution No. 251, dated 7 Aug. http://www.ensp.fiocruz.br/etica/docs/cns/Res251i.pdf
National Health Council (Brazil) (1999) Resolution No. 292, dated 8 July. http://www.conselho.saude.gov.br/resolucoes/1999/Res292_en.pdf
National Health Council (Brazil) (2000) Resolution No. 304, 9 Aug. http://www.conselho.saude.gov.br/resolucoes/2000/Res304_en.pdf
National Health Council (Brazil) (2008) Resolution No. 404, 1 Aug. http://conselho.saude.gov.br/resolucoes/2008/Reso_404.doc
Nijar GS (1996) In defence of local community knowledge and biodiversity: a conceptual framework and the essential elements of a rights regime. Third World Network, Penang, Malaysia
Nuffield Council on Bioethics (2005) The ethics of research related to healthcare in developing countries: a follow-up discussion paper. http://www.nuffieldbioethics.org/sites/default/files/HRRDC_Follow-up_Discussion_Paper.pdf
Pogge T (2008) World poverty and human rights, 2nd edn. Polity Press, Cambridge
Pottage A (1998) The inscription of life in law: genes, patents and bio-politics. Mod Law Rev 61:740–765
Research and Information System for Developing Countries (2007) World trade and development report 2007: building a development-friendly world trading system. Oxford University Press, Oxford
Schroeder D (2008) Post-trial obligations. RECIIS – Electron J Commun Inf Innov Health 2(Supl 1):Sup63–73
Schroeder D (2009) Informed consent: from medical research to traditional knowledge. In: Wynberg R, Schroeder D, Chennells R (eds) Indigenous peoples, consent and benefit sharing. Springer, Berlin, pp 27–51
Schroeder D, Pogge T (2009) Justice and the Convention on Biological Diversity. Ethics Int Aff 23(3):267–280
Schuklenk U (2004) The standard of care debate: against the myth of an ‘international consensus opinion’. J Med Ethics 30(2):194–197
Shanahan M, Masood E (2004) Biodiversity facts and figures. Science and Development Network, 1 Dec. http://www.scidev.net/en/agriculture-and-environment/features/biodiversity-facts-and-figures.html
Sheridan C (2005) EPO neem patent revocation revives biopiracy debate. Nat Biotechnol 23(5):511–512
Shiva V (1991) The violence of the green revolution: third world agriculture, ecology and politics. Zed Books, London
Simm K (2006) An argument for benefit-sharing through solidarity. Soc Justice Context 2:47–64
Simm K (2007a) Benefit sharing frameworks: justifications for and against benefit sharing in human genetic research. Report for GenBenefit. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_simm.pdf
Simm K (2007b) Benefit-sharing: a look at the history of an ethics concern. Nature Rev Genet 8:496. http://www.nature.com/nrg/journal/v8/n7/pdf/nrg2145.pdf
Tomossy GF, Ford J (2006) Globalisation and clinical trials. In: Bennett B, Tomossy GF (eds) Globalization and health: challenges for health law and bioethics. Springer, Dordrecht, pp 27–45
UN (1979) Agreement Governing the Activities of States on the Moon and Other Celestial Bodies. United Nations. http://www.unoosa.org/oosa/SpaceLaw/moon.html
UN (1982) Convention on the Law of the Sea. United Nations. http://www.un.org/depts/los/convention_agreements/texts/unclos/closindx.htm
UNESCO (1945) Constitution of the United Nations Educational, Scientific and Cultural Organization. Adopted in London on 16 November 1945 and amended by the General Conference at its 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 12th, 15th, 17th, 19th, 20th, 21st, 24th, 25th, 26th, 27th, 28th, 29th and 31st sessions. http://portal.unesco.org/en/ev.php-URL_ID=15244&URL_DO=DO_TOPIC&URL_SECTION=201.html
UNESCO (1997) Universal Declaration on the Human Genome and Human Rights. United Nations Educational, Scientific and Cultural Organization. http://www.un-documents.net/udhghr.htm
UNESCO (2005) Universal Declaration on Bioethics and Human Rights. Adopted by the General Conference of the United Nations Educational, Scientific and Cultural Organization, 33rd Session, 19 Oct. http://portal.unesco.org/en/ev.php-URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html
UNESCO (2007) Standard-setting in UNESCO. Information on a publication. http://portal.unesco.org/en/ev.php-URL_ID=41269&URL_DO=DO_TOPIC&URL_SECTION=201.html
UNESCO (n.d.) Building peace in the minds of men and women -– Introducing UNESCO: what we are. http://www.unesco.org/new/en/unesco/about-us/who-we-are/introducing-unesco/
Weijer C (2000) Benefit sharing and other protections for communities in genetic research. Clin Genet 58:367–368
Weisman J (1993) Organs as assets. Israel Law Rev 27:610–623
WHO (2007) International Health Regulations (2005): Areas of work for implementation. http://www.who.int/ihr/finalversion9Nov07.pdf
WMA (2004a) Clarification on Declaration of Helsinki. World Medical Association. http://www.wma.net/en/40news/20archives/2004/2004_24/
WMA (2004b) Declaration of Helsinki: ethical principles for medical research involving human subjects. World Medical Association. http://ohsr.od.nih.gov/guidelines/helsinki.html
WMA (2008) Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 18th World Medical Association General Assembly, Helsinki, Finland, June 1964, latest revision by the 59th WMA General Assembly, Seoul, Korea, October. http://www.wma.net/en/30publications/10policies/b3/index.html
Wolinsky H (2006) The battle of Helsinki: two troublesome paragraphs in the Declaration of Helsinki are causing a furore over medical research ethics. EMBO Rep 7(7):670–672
WTO (2006) The relationship between the TRIPS Agreement and the Convention on Biological Diversity: summary of issues raised and points made. Note by the secretariat, Council for Trade-Related Aspects of Intellectual Property Rights. IP/C/W/368/Rev.1, 8 Feb. http://www.wto.org/english/tratop_e/trips_e/ipcw368_e.pdf
WTO (n.d.) The Doha Declaration explained. World Trade Organization. http://www.wto.org/english/tratop_e/dda_e/dohaexplained_e.htm
Zong Z (2008) Should post-trial provision of beneficial experimental interventions be mandatory in developing countries? J Med Ethics 34:188–192
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Andanda, P., Schroeder, D., Chaturvedi, S., Mengesha, E., Hodges, T. (2013). Legal Frameworks for Benefit Sharing: From Biodiversity to Human Genomics. In: Schroeder, D., Cook Lucas, J. (eds) Benefit Sharing. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6205-3_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-6205-3_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6204-6
Online ISBN: 978-94-007-6205-3
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)